These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21187479)

  • 21. Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors.
    Iacob D; Cai J; Tsonis M; Babwah A; Chakraborty C; Bhattacharjee RN; Lala PK
    Endocrinology; 2008 Dec; 149(12):6187-97. PubMed ID: 18703624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours.
    Soria JC; Baselga J; Hanna N; Laurie SA; Bahleda R; Felip E; Calvo E; Armand JP; Shepherd FA; Harbison CT; Berman D; Park JS; Zhang S; Vakkalagadda B; Kurland JF; Pathak AK; Herbst RS
    Eur J Cancer; 2013 May; 49(8):1815-24. PubMed ID: 23490650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via alpha(3)beta(1) and alpha(6)beta(4) integrins.
    Pouliot N; Nice EC; Burgess AW
    Exp Cell Res; 2001 May; 266(1):1-10. PubMed ID: 11339819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.
    Huang D; Ding Y; Li Y; Luo WM; Zhang ZF; Snider J; Vandenbeldt K; Qian CN; Teh BT
    Cancer Res; 2010 Feb; 70(3):1053-62. PubMed ID: 20103629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signaling.
    Kanda R; Kawahara A; Watari K; Murakami Y; Sonoda K; Maeda M; Fujita H; Kage M; Uramoto H; Costa C; Kuwano M; Ono M
    Cancer Res; 2013 Oct; 73(20):6243-53. PubMed ID: 23872583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor.
    Wang D; Tang F; Wang S; Jiang Z; Zhang L
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):173-83. PubMed ID: 21638122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adhesion, actin cytoskeleton organisation and the spreading of colon adenocarcinoma cells induced by EGF are mediated by alpha2beta1 integrin low clustering through focal adhesion kinase.
    Pichard V; Honoré S; Kovacic H; Li C; Prevôt C; Briand C; Rognoni JB
    Histochem Cell Biol; 2001 Oct; 116(4):337-48. PubMed ID: 11702192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
    Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
    Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of carbon ion irradiation on epidermal growth factor receptor signaling and glioma cell migration in comparison to conventional photon irradiation.
    Stahler C; Roth J; Cordes N; Taucher-Scholz G; Mueller-Klieser W
    Int J Radiat Biol; 2013 Jun; 89(6):454-61. PubMed ID: 23363301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions.
    Wang XQ; Sun P; Paller AS
    J Invest Dermatol; 2005 Apr; 124(4):839-48. PubMed ID: 15816844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.
    Bessette DC; Tilch E; Seidens T; Quinn MC; Wiegmans AP; Shi W; Cocciardi S; McCart-Reed A; Saunus JM; Simpson PT; Grimmond SM; Lakhani SR; Khanna KK; Waddell N; Al-Ejeh F; Chenevix-Trench G
    PLoS One; 2015; 10(5):e0125232. PubMed ID: 25969993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzoxazine Dimer Analogue Targets Integrin β3 in Lung Cancer Cells and Suppresses Anoikis Resistance and Migration.
    Sriratanasak N; Nonpanya N; Wattanathana W; Chanvorachote P
    Anticancer Res; 2020 May; 40(5):2583-2589. PubMed ID: 32366403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sunitinib--CLIO conjugate: a VEGFR/PDGFR-targeting active MR probe.
    Noh GT; Kim MH; Suh JY; Song Y; Lee CK; Baek JH; Lee YS; Cho G; Kim E; Kim YR; Cho HJ; Lim D; Kim JK
    Mol Imaging Biol; 2014 Jun; 16(3):340-9. PubMed ID: 24185817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.
    Goel S; Chen F; Hong H; Valdovinos HF; Hernandez R; Shi S; Barnhart TE; Cai W
    ACS Appl Mater Interfaces; 2014 Dec; 6(23):21677-85. PubMed ID: 25353068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cucurbitacin B purified from Ecballium elaterium (L.) A. Rich from Tunisia inhibits α5β1 integrin-mediated adhesion, migration, proliferation of human glioblastoma cell line and angiogenesis.
    Touihri-Barakati I; Kallech-Ziri O; Ayadi W; Kovacic H; Hanchi B; Hosni K; Luis J
    Eur J Pharmacol; 2017 Feb; 797():153-161. PubMed ID: 28108377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targetting αvβ3 and α5β1 integrins with Ecballium elaterium (L.) A. Rich. seed oil.
    Touihri-Barakati I; Kallech-Ziri O; Boulila A; Khwaldia K; Marrakchi N; Hanchi B; Hosni K; Luis J
    Biomed Pharmacother; 2016 Dec; 84():1223-1232. PubMed ID: 27810778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis.
    Hu J; Wang W; Liu C; Li M; Nice E; Xu H
    J Exp Clin Cancer Res; 2019 Aug; 38(1):381. PubMed ID: 31462260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells.
    Alamón C; Dávila B; Cerecetto H; Couto M
    Chem Biol Drug Des; 2023 Jun; 101(6):1435-1445. PubMed ID: 36746676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metalloproteinase dependent reduction of cell surface cluster determinants upon the induction of apoptosis.
    Magro A; Magro A; Shrestha S; Brundage K; Rankin G
    Int J Oncol; 2014 May; 44(5):1539-50. PubMed ID: 24626736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.